AMRING Trademark

Trademark Overview

On Thursday, June 1, 2017, a trademark application was filed for AMRING with the United States Patent and Trademark Office. The USPTO has given the AMRING trademark a serial number of 87471074. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2019. This trademark is owned by Amring Holding SA. The AMRING trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products and substances for use in the prevention and treatment of urinary, blood, and dermal disorders and diseases

Medical apparatus for introducing pharmaceutical preparations into the human body; syringes for medical purposes and for injections
amring

General Information

Serial Number87471074
Word MarkAMRING
Filing DateThursday, June 1, 2017
Status700 - REGISTERED
Status DateTuesday, May 14, 2019
Registration Number5748167
Registration DateTuesday, May 14, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesPharmaceutical products and substances for use in the prevention and treatment of urinary, blood, and dermal disorders and diseases
Goods and ServicesMedical apparatus for introducing pharmaceutical preparations into the human body; syringes for medical purposes and for injections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 8, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNORDIC PHARMA, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBERWYN, PA 19312
Party NameAMRING PHARMACEUTICALS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBERWYN, PA 19312
Party NameAmring Holding SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLausanne 1005
CH
Party NameAmring Holding SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLausanne 1005
CH
Party NameAmring Holding SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLausanne 1005
CH

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 5, 2017NEW APPLICATION ENTERED
Thursday, June 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 19, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 20, 2017NON-FINAL ACTION E-MAILED
Friday, August 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 1, 2018ASSIGNED TO LIE
Tuesday, January 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2018NON-FINAL ACTION WRITTEN
Friday, January 19, 2018NON-FINAL ACTION E-MAILED
Friday, January 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 3, 2018ASSIGNED TO LIE
Friday, August 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2018NON-FINAL ACTION E-MAILED
Wednesday, August 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 29, 2018NON-FINAL ACTION WRITTEN
Tuesday, September 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 21, 2019TEAS DELETE 1(B) BASIS RECEIVED
Thursday, March 21, 2019NOTICE OF ALLOWANCE CANCELLED
Thursday, April 11, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 18, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 17, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

amring medical pharmaceutical introducing apparatus preparations body injections purposes syringes human